Trial intelligence / Profile preview

Melatonin as Adjuvant Therapy in Childhood Pneumonia

NCT06949904Phase 2Recruiting

Start
May 2025
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of melatonin in pneumonia. Started May 2025; status: recruiting.

02

Drugs

melatonin
03

Conditions

pneumonia

Beyond the preview

Go deeper on NCT06949904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06949904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call